SUNNYVALE, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced that its executives will be speaking at the following
investor conferences, and invited investors to participate via webcast.
Thomas Weisel Partners Healthcare Conference, Boston, MA
Wednesday, September 3, 2008 at 2.05 p.m. Eastern Time
R.W. Baird Small Cap Healthcare Conference, New York, NY
Wednesday, September 10, 2008 at 9.00 a.m. Eastern Time
UBS Global Life Sciences Conference, New York, NY
Tuesday, September 23, 2008 at 9.00 a.m. Eastern Time
To access the live webcasts for these events, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the schedule start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the presentation and will remain available for at least 90 days.
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand
molecular diagnostics company that develops, manufactures, and markets
fully-integrated systems and tests for genetic analysis in the clinical,
industrial and biothreat markets. The Company's systems enable rapid,
sophisticated genetic testing for organisms and genetic-based diseases by
automating otherwise complex manual laboratory procedures. Cepheid's
easy-to-use systems integrate a number of complicated and time-intensive
steps, including sample preparation, DNA amplification and detection, which
enable the analysis of complex biological samples in its proprietary test
cartridges. Through its stro
Copyright©2008 PR Newswire.
All rights reserved